| Joshua Goodrum, DO | |
|
2205 Ashland St Ste 102, Ashland, OR 97520-1995 | |
| (541) 526-9016 | |
| (541) 543-2491 |
| Full Name | Joshua Goodrum |
|---|---|
| Gender | Male |
| Speciality | Osteopathic Manipulative Medicine |
| Experience | 16 Years |
| Location | 2205 Ashland St Ste 102, Ashland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538318233 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS015562 (Pennsylvania) | Secondary |
| 204D00000X | Neuromusculoskeletal Medicine & Omm | DO197677 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Ashland Community Hospital | Ashland, OR | Hospital |
| Entity Name | Goodrum Medical Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689281867 PECOS PAC ID: 7113347956 Enrollment ID: O20201016002707 |
News Archive
Rockport Healthcare Group announced it is adding more than 25,000 OptumHealth physical medicine specialists to its workers' compensation Preferred Provider Organization (PPO) network. The PPO program launched May 1, 2010.
J. Knipper and Company, Inc., the largest supplier of end-to-end samples management services to the U.S. pharmaceutical industry, announced today that the Company has acquired MediMedia Health's sample management lines of business. These services include direct-to- provider sample fulfillment, patient assistance programs and animal health services, as well as call center and regulatory compliance services that accompany these activities. Terms of the agreement were not disclosed.
An advance by UCLA neuroscientists could lead to a better understanding of astrocytes, a star-shaped brain cell believed to play a key role in neurological disorders like Lou Gehrig's, Alzheimer's and Huntington's disease.
Orthovita, Inc., an orthobiologics and biosurgery company, announced that it received 510(k) clearance from the U.S. Food and Drug Administration to market VITOMATRIX Bone Graft Substitute as a bone grafting material in certain dental procedures.
Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.
› Verified 7 days ago
| Entity Name | Onepeak Southern Oregon Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740917558 PECOS PAC ID: 5395129670 Enrollment ID: O20220906001662 |
News Archive
Rockport Healthcare Group announced it is adding more than 25,000 OptumHealth physical medicine specialists to its workers' compensation Preferred Provider Organization (PPO) network. The PPO program launched May 1, 2010.
J. Knipper and Company, Inc., the largest supplier of end-to-end samples management services to the U.S. pharmaceutical industry, announced today that the Company has acquired MediMedia Health's sample management lines of business. These services include direct-to- provider sample fulfillment, patient assistance programs and animal health services, as well as call center and regulatory compliance services that accompany these activities. Terms of the agreement were not disclosed.
An advance by UCLA neuroscientists could lead to a better understanding of astrocytes, a star-shaped brain cell believed to play a key role in neurological disorders like Lou Gehrig's, Alzheimer's and Huntington's disease.
Orthovita, Inc., an orthobiologics and biosurgery company, announced that it received 510(k) clearance from the U.S. Food and Drug Administration to market VITOMATRIX Bone Graft Substitute as a bone grafting material in certain dental procedures.
Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua Goodrum, DO 2205 Ashland St Ste 102, Ashland, OR 97520-1995 Ph: (541) 526-9016 | Joshua Goodrum, DO 2205 Ashland St Ste 102, Ashland, OR 97520-1995 Ph: (541) 526-9016 |
News Archive
Rockport Healthcare Group announced it is adding more than 25,000 OptumHealth physical medicine specialists to its workers' compensation Preferred Provider Organization (PPO) network. The PPO program launched May 1, 2010.
J. Knipper and Company, Inc., the largest supplier of end-to-end samples management services to the U.S. pharmaceutical industry, announced today that the Company has acquired MediMedia Health's sample management lines of business. These services include direct-to- provider sample fulfillment, patient assistance programs and animal health services, as well as call center and regulatory compliance services that accompany these activities. Terms of the agreement were not disclosed.
An advance by UCLA neuroscientists could lead to a better understanding of astrocytes, a star-shaped brain cell believed to play a key role in neurological disorders like Lou Gehrig's, Alzheimer's and Huntington's disease.
Orthovita, Inc., an orthobiologics and biosurgery company, announced that it received 510(k) clearance from the U.S. Food and Drug Administration to market VITOMATRIX Bone Graft Substitute as a bone grafting material in certain dental procedures.
Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.
› Verified 7 days ago